| Biocon Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532523 |
NSE Symbol : BIOCON |
P/E(TTM) : - |
|
ISIN Demat : INE376G01013 |
Div & Yield% : 0.14 |
EPS(TTM) : 0.65 |
|
Book Value(₹) : 90.88 |
Market Cap(₹Cr) : 43,311.65 |
Face Value(₹) : 5.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 510.60 | 532.60 | 562.80 | 518.70 | 513.20 | 506.70 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 510.60 | 532.60 | 562.80 | 518.70 | 513.20 | 506.70 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 41.90 | 38.90 | 48.50 | 69.60 | 55.70 | 1,917.60 |
| Total Income | 552.50 | 571.50 | 611.30 | 588.30 | 568.90 | 2,424.30 |
| Total Expenditure | 465.70 | 480.40 | 491.50 | 456.70 | 441.20 | 550.70 |
| PBIDT | 86.80 | 91.10 | 119.80 | 131.60 | 127.70 | 1,873.60 |
| Interest | 55.20 | 39.50 | 56.00 | 55.00 | 48.30 | 48.10 |
| PBDT | 31.60 | 51.60 | 63.80 | 76.60 | 79.40 | 1,825.50 |
| Depreciation | 30.50 | 29.80 | 30.90 | 30.60 | 29.80 | 29.40 |
| Tax | 2.40 | -9.30 | 12.30 | 8.20 | 3.90 | -12.90 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.20 | 17.10 | -3.40 | 3.10 | -0.90 | -1.80 |
| Reported Profit After Tax | 0.90 | 14.00 | 24.00 | 34.70 | 46.60 | 1,810.80 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | -3.92 | 18.15 | 1,853.60 |
| Adjusted Profit After Extra-ordinary item | 0.90 | 14.00 | 24.00 | 38.62 | 28.45 | -42.80 |
| EPS (Unit Curr.) | 0.01 | 0.12 | 0.20 | 0.29 | 0.39 | 15.17 |
| EPS (Adj) (Unit Curr.) | 0.01 | 0.12 | 0.20 | 0.29 | 0.39 | 15.17 |
| Calculated EPS (Unit Curr.) | 0.01 | 0.12 | 0.20 | 0.29 | 0.39 | 15.08 |
| Calculated EPS (Adj) (Unit Curr.) | 0.01 | 0.12 | 0.20 | 0.29 | 0.39 | 15.08 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.03 | 0.47 | 0.80 | 1.16 | 1.55 | 60.33 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.03 | 0.47 | 0.80 | 1.16 | 1.55 | 60.33 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 600.30 | 600.30 | 600.30 | 600.30 | 600.30 | 600.30 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 17.00 | 17.10 | 21.29 | 25.37 | 24.88 | 369.77 |
| PBDTM(%) | 6.19 | 9.69 | 11.34 | 14.77 | 15.47 | 360.27 |
| PATM(%) | 0.18 | 2.63 | 4.26 | 6.69 | 9.08 | 357.37 |